调和肝脾中医经典方剂治疗腹泻型肠易激综合征疗效网状Meta 分析
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R574.4

基金项目:


Efficacy of Traditional Chinese Medicine Formulas for Regulating Liver and Spleen in the Treatment of Diarrheal-Predominant Irritable Bowel Syndrome:A Network Metaanalysis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:通过网状Meta 分析(NMA) 比较不同具有调和肝脾作用的中医经典方剂治疗腹泻型肠易 激综合征(IBS-D) 的疗效。方法:检索中国知网(CNKI) 及PubMed 等7 个中英文数据库从建库起至 2022 年12 月有关调和肝脾类中医经典方剂治疗IBS-D 的随机对照试验(RCT)。使用R 语言软件中的GeMTC 包进行统计分析。结果:共纳入52 项RCT,所有研究均以常规西药为对照措施,涉及8 种中医经典方剂干预 措施,NMA 结果显示,合方治疗优于单方治疗,各干预措施成为最佳的概率排序如下:痛泻要方合柴胡疏肝 散(84.5%) >柴胡疏肝散(75.8%) >痛泻要方合参苓白术散(64.1%) >痛泻要方合四逆散(63.7%) >痛 泻要方合常规西药(56.1%) >四逆散(45.4%) >痛泻要方合四君子汤(45.0%) >痛泻要方(15.5%) >常 规西药(0)。在不良反应方面中药具有良好的安全性。结论:痛泻要方合柴胡疏肝散可能为最佳治疗IBS-D 的调和肝脾方剂。该研究尚存一定局限性,期待更多高质量的RCT 研究予以验证。

    Abstract:

    Abstract:Objective:To compare the efficacy of different traditional Chinese medicine (TCM) formulas for regulating liver and spleen in the treatment of diarrheal irritable bowel syndrome (IBS- D) through Network Meta- analysis (NMA). Methods: Randomized controlled trials (RCT) on the treatment of IBS- D with TCM prescriptions for harmonizing liver and spleen were searched from seven Chinese and English databases including CNKI and PubMed from establishment to December 2022. The GeMTC package in R language software was used for statistical analysis. Results:A total of 52 RCT were included,all of which took conventional western medicine as the control measure, involving eight TCM intervention measures. NMA results showed that combination therapy was superior to single therapy,and the probability of each intervention becoming the best was ranked as follows:Tongxie Yaofang Decoction combined with Chaihu Shugan San (84.5% ) >Chaihu Shugan San (75.8% ) >Tongxie Yaofang Decoction combined with Shenling Baizhu San (64.1% ) >Tongxie Yaofang Decoction combined with Sini San (63.7% ) >Tongxie Yaofang Decoction combined with conventional western medicine (56.1% ) >Sini San (45.4% ) >Tongxie Yaofang Decoction combined with Sijunzi Decoction (45.0% ) >Tongxie Yaofang Decoction combined with Sijunzi Decoction (45.0% ) >Tongxie Yaofang Decoction (15.5% ) >conventional western medicine (0). TCM has good safety in terms of adverse reactions. Conclusion;Tongxie Yaofang Decoction combined with Chaihu Shugan San may be the best prescription for regulating liver and spleen in treating IBS-D. This study still has some limitations,and more high-quality RCT studies are expected to verify it.

    参考文献
    相似文献
    引证文献
引用本文

乔娜丽,李宁宁,黄冠华,袁宝健.调和肝脾中医经典方剂治疗腹泻型肠易激综合征疗效网状Meta 分析[J].新中医,2023,55(24):14-23

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-12-30
  • 出版日期:
文章二维码